• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭中的心房电生理重塑与房颤

Atrial Electrophysiological Remodeling and Fibrillation in Heart Failure.

作者信息

Pandit Sandeep V, Workman Antony J

机构信息

Department of Internal Medicine - Cardiology, Center for Arrhythmia Research, University of Michigan, Ann Arbor, MI, USA.

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

出版信息

Clin Med Insights Cardiol. 2016 Oct 31;10(Suppl 1):41-46. doi: 10.4137/CMC.S39713. eCollection 2016.

DOI:10.4137/CMC.S39713
PMID:27812293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5089851/
Abstract

Heart failure (HF) causes complex, chronic changes in atrial structure and function, which can cause substantial electrophysiological remodeling and predispose the individual to atrial fibrillation (AF). Pharmacological treatments for preventing AF in patients with HF are limited. Improved understanding of the atrial electrical and ionic/molecular mechanisms that promote AF in these patients could lead to the identification of novel therapeutic targets. Animal models of HF have identified numerous changes in atrial ion currents, intracellular calcium handling, action potential waveform and conduction, as well as expression and signaling of associated proteins. These studies have shown that the pattern of electrophysiological remodeling likely depends on the duration of HF, the underlying cardiac pathology, and the species studied. In atrial myocytes and tissues obtained from patients with HF or left ventricular systolic dysfunction, the data on changes in ion currents and action potentials are largely equivocal, probably owing mainly to difficulties in controlling for the confounding influences of multiple variables, such as patient's age, sex, disease history, and drug treatments, as well as the technical challenges in obtaining such data. In this review, we provide a summary and comparison of the main animal and human electrophysiological studies to date, with the aim of highlighting the consistencies in some of the remodeling patterns, as well as identifying areas of contention and gaps in the knowledge, which warrant further investigation.

摘要

心力衰竭(HF)会导致心房结构和功能发生复杂的慢性变化,这可能会引起显著的电生理重塑,并使个体易患心房颤动(AF)。用于预防HF患者发生AF的药物治疗方法有限。更好地了解促进这些患者发生AF的心房电和离子/分子机制,可能会带来新治疗靶点的发现。HF动物模型已确定心房离子电流、细胞内钙处理、动作电位波形和传导以及相关蛋白的表达和信号传导存在众多变化。这些研究表明,电生理重塑模式可能取决于HF的持续时间、潜在的心脏病理状况以及所研究的物种。在从HF患者或左心室收缩功能障碍患者获取的心房肌细胞和组织中,关于离子电流和动作电位变化的数据大多模棱两可,这可能主要是由于难以控制多个变量的混杂影响,如患者的年龄、性别、病史和药物治疗,以及获取此类数据时的技术挑战。在本综述中,我们对迄今为止主要的动物和人类电生理研究进行了总结和比较,目的是突出一些重塑模式中的一致性,以及确定存在争议的领域和知识空白,这些都值得进一步研究。

相似文献

1
Atrial Electrophysiological Remodeling and Fibrillation in Heart Failure.心力衰竭中的心房电生理重塑与房颤
Clin Med Insights Cardiol. 2016 Oct 31;10(Suppl 1):41-46. doi: 10.4137/CMC.S39713. eCollection 2016.
2
Profibrotic, Electrical, and Calcium-Handling Remodeling of the Atria in Heart Failure Patients With and Without Atrial Fibrillation.伴有和不伴有心房颤动的心力衰竭患者心房的促纤维化、电活动及钙处理重塑
Front Physiol. 2018 Oct 9;9:1383. doi: 10.3389/fphys.2018.01383. eCollection 2018.
3
Fibroblast electrical remodeling in heart failure and potential effects on atrial fibrillation.心力衰竭中的成纤维细胞电重塑及其对心房颤动的潜在影响。
Biophys J. 2014 Nov 18;107(10):2444-55. doi: 10.1016/j.bpj.2014.10.014.
4
Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K) channels in murine disease models: focus on TASK-1.心房颤动和心力衰竭相关的双孔钾 (K) 通道在小鼠疾病模型中的重构:聚焦 TASK-1。
Basic Res Cardiol. 2018 Jun 7;113(4):27. doi: 10.1007/s00395-018-0687-9.
5
Future perspectives in the pharmacological treatment of atrial fibrillation and ventricular arrhythmias in heart failure.心力衰竭中心房颤动和室性心律失常药物治疗的未来展望
Curr Pharm Des. 2015;21(8):1011-29. doi: 10.2174/1381612820666141029101305.
6
Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation.犬心房颤动模型中心房大小及排空功能的重塑
Cardiovasc Res. 2001 Nov;52(2):217-25. doi: 10.1016/s0008-6363(01)00377-7.
7
Molecular basis of electrical remodeling in atrial fibrillation.心房颤动电重构的分子基础。
J Mol Cell Cardiol. 2000 Jun;32(6):1101-17. doi: 10.1006/jmcc.2000.1147.
8
Heart failure-induced atrial remodelling promotes electrical and conduction alternans.心力衰竭引起的心房重构促进电和传导交替。
PLoS Comput Biol. 2020 Jul 13;16(7):e1008048. doi: 10.1371/journal.pcbi.1008048. eCollection 2020 Jul.
9
Cloning, functional characterization, and remodeling of K2P3.1 (TASK-1) potassium channels in a porcine model of atrial fibrillation and heart failure.心房颤动和心力衰竭猪模型中K2P3.1(TASK-1)钾通道的克隆、功能表征及重塑
Heart Rhythm. 2014 Oct;11(10):1798-805. doi: 10.1016/j.hrthm.2014.06.020. Epub 2014 Jun 18.
10
Mechanistic investigation of Ca2+ alternans in human heart failure and its modulation by fibroblasts.钙波交替在人类心力衰竭中的机制研究及其受成纤维细胞的调节。
PLoS One. 2019 Jun 18;14(6):e0217993. doi: 10.1371/journal.pone.0217993. eCollection 2019.

引用本文的文献

1
Predictive value of the systemic immune inflammation index in recurrence of atrial fibrillation after radiofrequency catheter ablation.全身免疫炎症指数对射频导管消融术后心房颤动复发的预测价值
World J Cardiol. 2025 Jan 26;17(1):102981. doi: 10.4330/wjc.v17.i1.102981.
2
Mechanism-based targeting of cardiac arrhythmias by phytochemicals and medicinal herbs: A comprehensive review of preclinical and clinical evidence.植物化学物质和草药基于机制的心律失常靶向治疗:临床前和临床证据的全面综述
Front Cardiovasc Med. 2022 Sep 29;9:990063. doi: 10.3389/fcvm.2022.990063. eCollection 2022.
3
Arrhythmogenic Remodeling in the Failing Heart.心律失常性重构在心力衰竭中的作用。
Cells. 2021 Nov 17;10(11):3203. doi: 10.3390/cells10113203.
4
Latest Insights into Mechanisms behind Atrial Cardiomyopathy: It Is Not always about Ventricular Function.心房心肌病背后机制的最新见解:并非总是与心室功能有关。
Diagnostics (Basel). 2021 Mar 5;11(3):449. doi: 10.3390/diagnostics11030449.
5
The Therapeutic Potential of MicroRNAs in Atrial Fibrillation.miRNAs 在心房颤动中的治疗潜力。
Mediators Inflamm. 2020 Mar 12;2020:3053520. doi: 10.1155/2020/3053520. eCollection 2020.
6
Profibrotic, Electrical, and Calcium-Handling Remodeling of the Atria in Heart Failure Patients With and Without Atrial Fibrillation.伴有和不伴有心房颤动的心力衰竭患者心房的促纤维化、电活动及钙处理重塑
Front Physiol. 2018 Oct 9;9:1383. doi: 10.3389/fphys.2018.01383. eCollection 2018.
7
Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure.参松养心胶囊通过抑制心肌梗死后心力衰竭大鼠的心房纤维化来降低房颤易感性。
Drug Des Devel Ther. 2018 Oct 10;12:3407-3418. doi: 10.2147/DDDT.S182834. eCollection 2018.
8
Calcium Dynamics and Cardiac Arrhythmia.钙动力学与心律失常
Clin Med Insights Cardiol. 2017 Dec 3;11:1179546817739523. doi: 10.1177/1179546817739523. eCollection 2017.
9
Atrial Fibrillation in Heart Failure: a Therapeutic Challenge of Our Times.心力衰竭中的心房颤动:当今时代的治疗挑战
Korean Circ J. 2017 Sep;47(5):644-662. doi: 10.4070/kcj.2017.0040. Epub 2017 Aug 22.

本文引用的文献

1
Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial.导管消融术与胺碘酮治疗心力衰竭伴植入装置患者持续性心房颤动的疗效比较:AATAC多中心随机试验结果
Circulation. 2016 Apr 26;133(17):1637-44. doi: 10.1161/CIRCULATIONAHA.115.019406. Epub 2016 Mar 30.
2
Compromised redox homeostasis, altered nitroso-redox balance, and therapeutic possibilities in atrial fibrillation.心房颤动中氧化还原稳态受损、亚硝基 - 氧化还原平衡改变及治疗可能性
Cardiovasc Res. 2016 Apr 1;109(4):510-8. doi: 10.1093/cvr/cvw012. Epub 2016 Jan 19.
3
Comorbidity of atrial fibrillation and heart failure.心房颤动与心力衰竭的并存。
Nat Rev Cardiol. 2016 Mar;13(3):131-47. doi: 10.1038/nrcardio.2015.191. Epub 2015 Dec 10.
4
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.欧洲心律协会/心力衰竭协会关于心力衰竭心律失常的联合共识文件,得到心律协会和亚太心律协会认可。
Eur J Heart Fail. 2015 Sep;17(9):848-74. doi: 10.1002/ejhf.338. Epub 2015 Aug 21.
5
Long noncoding RNAs and microRNAs in cardiovascular pathophysiology.长链非编码 RNA 和 microRNAs 在心血管病理生理学中的作用。
Circ Res. 2015 Feb 13;116(4):751-62. doi: 10.1161/CIRCRESAHA.116.303549.
6
Fibroblast inward-rectifier potassium current upregulation in profibrillatory atrial remodeling.成纤维细胞内向整流钾电流在纤维颤动性心房重构中的上调。
Circ Res. 2015 Feb 27;116(5):836-45. doi: 10.1161/CIRCRESAHA.116.305326. Epub 2015 Jan 21.
7
Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.射血分数保留或降低的晚期心力衰竭患者的左心房重构与功能
Circ Heart Fail. 2015 Mar;8(2):295-303. doi: 10.1161/CIRCHEARTFAILURE.114.001667. Epub 2015 Jan 15.
8
Perturbed atrial calcium handling in an ovine model of heart failure: potential roles for reductions in the L-type calcium current.心力衰竭绵羊模型中心房钙处理紊乱:L型钙电流降低的潜在作用
J Mol Cell Cardiol. 2015 Feb;79:169-79. doi: 10.1016/j.yjmcc.2014.11.017. Epub 2014 Nov 22.
9
Fibroblast electrical remodeling in heart failure and potential effects on atrial fibrillation.心力衰竭中的成纤维细胞电重塑及其对心房颤动的潜在影响。
Biophys J. 2014 Nov 18;107(10):2444-55. doi: 10.1016/j.bpj.2014.10.014.
10
Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.雷诺嗪在心力衰竭情况下能有效抑制心房颤动。
Circ Heart Fail. 2014 Jul;7(4):627-33. doi: 10.1161/CIRCHEARTFAILURE.114.001129. Epub 2014 May 29.